Analyst Research Report Snapshot

Title:

Cipla increases 1.5% - outperforming 84% of stocks

Price:

$5.00

Provider:

News Bites Pty Limited

Date:

24 Jul 2013

Pages:

16

Type:

AcrobatPDF

Companies referenced:

CIPL.NS

Available for Immediate Download
Summary:

Cipla Ltd. (NSE:CIPLA), India's 4th largest pharmaceuticals company by market capitalisation, increased Rs6.15 (or 1.5%) to close at Rs415.30, ending a two-day streak of losses. In the Indian market of 2,282 stocks traded today, the stock has a 6-month relative price strength of 84 which means it...

Why buy analyst research?

  • Institutional quality research
  • Available for Immediate Download
  • Detailed company or industry insight
  • Print or save
  • 24 hour customer support
Return to previous page without adding this item to your cart.
Email Customer Support.

About Analyst Research

Analyst research reports are available for immediate download after purchase. You will have unlimited access to the report for 24 hours after purchase, to download, print or save it as many times as you wish. Analyst Research provided by Reuters does not constitute investment advice, and is not endorsed by Reuters Research. This information is protected by copyright and intellectual property laws. More information on Analyst Research.